Abzena nabs $65M to bolster manufacturing and research services on both sides of the pond

Abzena nabs $65M to bolster manufacturing and research services on both sides of the pond

Source: 
Fierce Pharma
snippet: 

Roughly one year after dropping designs on a $200 million biologics plant in North Carolina, antibody-drug conjugate specialist Abzena has snared a fresh round of funding to overhaul manufacturing on both sides of the Atlantic.